Faeth Therapeutics, Inc. (FTH) — Financial Flexibility Index
Faeth Therapeutics, Inc. (FTH) has a Financial Flexibility Index of -0.76x as of March 2026. Free cash flow of $-10.73 Million (operating CF $-10.73 Million minus capex $6.00K) represents -1% of total liabilities ($14.19 Million). Check Faeth Therapeutics, Inc. (FTH) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Faeth Therapeutics, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Faeth Therapeutics, Inc. across 8 annual periods. See FTH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Faeth Therapeutics, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Faeth Therapeutics, Inc.. For the full company profile including market capitalisation, see Faeth Therapeutics, Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.74x | $-20.44 Million | $-20.45 Million | $4.31 Million | ▼ -34.9% |
| 2024 | -3.52x | $-24.52 Million | $-24.67 Million | $6.97 Million | ▼ -4.7% |
| 2023 | -3.36x | $-31.84 Million | $-32.02 Million | $9.48 Million | ▼ -29.9% |
| 2022 | -2.59x | $-38.70 Million | $-39.03 Million | $14.97 Million | ▲ +38.5% |
| 2021 | -4.21x | $-28.23 Million | $-30.26 Million | $6.71 Million | ▼ -41.1% |
| 2020 | -2.98x | $-16.50 Million | $-17.70 Million | $5.54 Million | ▼ -2345.4% |
| 2019 | -0.12x | $-8.52 Million | $-8.57 Million | $69.88 Million | ▲ +34.4% |
| 2018 | -0.19x | $-10.28 Million | $-10.31 Million | $55.33 Million | — |